Delivery Order SPE2DR25D7005-SPE2DR26F3FCF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,312.85 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL). The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was competitively awarded with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a task order under AmerisourceBergen's parent company...
- The Defense Logistics Agency awarded a delivery order valued at $4,109.75 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL units). The contract, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, was competitively awarded with no set-aside designation and employs firm fixed-price pricing. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a $4,536.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Atropine 1 mg/ml vials. This non-set-aside contract, which carries an ultimate completion date of January 30, 2026, represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The DLA's Medical Supply Chain maintains this $999,999,999.00 IDC through...
- The Defense Logistics Agency awarded a delivery order valued at $3,576.02 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials on January 29, 2026. The contract is competitively awarded with no set-aside designation and carries a firm fixed-price structure with a completion date of January 30, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical...
- The Defense Logistics Agency awarded a $1,417.28 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atropine 1 mg/10 ml syringes (10 ml quantity). This firm fixed price contract is scheduled for completion by July 30, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation, and the product will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.74 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 ml syringes on January 28, 2026, with a completion date of January 29, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for a critical pharmaceutical commodity. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,690.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Atropine 1 mg/mL vials. This is a non-set-aside competitive award with an ultimate completion date of January 30, 2026, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a $1,127.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials, with a completion date of January 20, 2026. This non-set-aside, competitively awarded contract reflects standard pharmaceutical procurement practices for federal medical supply chain operations. The contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,046.81 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Atropine 1 mg/mL vials. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of July 21, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3FCFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,078.88 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 ml syringes on January 29, 2026, with completion expected by January 30, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Atropine is a critical emergency medical supply used in military and federal healthcare systems for treating nerve agent exposure and other medical emergencies. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor that holds additional significant IDCs with the Defense Logistics Agency and Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/28/26 |